Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Mol Cancer Res. 2019 Jun 20;17(8):1605–1612. doi: 10.1158/1541-7786.MCR-19-0115

Table 1:

Description of the population under study

Variable Non-WTC (n=14)
N (%)
WTC (n=15)
N (%)
P-value^
Gleason Score 6 4 (28.6) 4 (26.7) 0.912
7 8* (57.1) 10# (66.7)
8 1 (7.1) 1 (6.7)
9 1 (7.1) 0 (0)
T$ 2c 9 (64.3) 10 (71.4) 0.53
3a 2 (14.3) 3 (21.4)
3b 3 (21.4) 1 (7.2)
Race White 12 (85.7) 8 (53.3) 0.365
Other 2 (14.3) 4(26.7)
Missing 0 (0) 3 (20.0)
Age (years) mean (SD) 55.07 (6.17) 54.7 (6.76) 0.895
Time from exposure to diagnosis Months (mean ±SD) - 81.4 ±42
WTC Exposure level$ Intermediate 9 (64.3)
High 4 (28.6)
Very high 1 (7.1)
^

Fisher’s Exact Test (non-missing values) for categorical variables, Wilcoxon Rank Sum Test for continuous variables

*:

Group Gleason 2 (n= 4); Group Gleason 3 (n=4);

#:

Group Gleason 2 (n= 8); Group Gleason 3 (n=2)

$

Information missing in 1 WTC case

1 WTC case was N+; all cases were M negative.